Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Stephanie Rouanet"'
Autor:
Ana Bouzaglou, Ines Aubenas, Hind Abbou, Stephanie Rouanet, Marie Carbonnel, Paul Pirtea, Jean Marc Bernard Ayoubi
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Objectives: Maternal age has been increasing for several decades with many of these late pregnancies between 40 and 45 years old. The main objective of this study is to assess whether maternal age is an independent factor of obstetric, fetal, and neo
Externí odkaz:
https://doaj.org/article/531f36ff440743689c06440a75559058
Autor:
Carole Maupain, Pierre Baudinaud, Stephanie Rouanet, Estelle Gandjbakhch, Mikael Laredo, Guillaume Duthoit, Françoise Hidden-Lucet, Alban Redheuil, Nicolas Badenco, Xavier Waintraub
Publikováno v:
Canadian Journal of Cardiology
Canadian Journal of Cardiology, Elsevier, 2021, ⟨10.1016/j.cjca.2021.02.018⟩
Canadian Journal of Cardiology, Elsevier, 2021, ⟨10.1016/j.cjca.2021.02.018⟩
The new 5-year ventricular arrhythmia (VA) occurrence risk model is a major breakthrough for arrhythmia risk stratification in the challenging population of patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). In the original study,
Autor:
Hind Abbou, Paul Pirtea, Stephanie Rouanet, Ana Bouzaglou, Marie Carbonnel, Ines Aubenas, Jean-Marc Ayoubi
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine, Vol 7 (2020)
Objectives: Maternal age has been increasing for several decades with many of these late pregnancies between 40 and 45 years old. The main objective of this study is to assess whether maternal age is an independent factor of obstetric, fetal, and neo
Autor:
Marc Popelier, Olivier Bourron, Sophie Jacqueminet, Stephanie Rouanet, Cécile Ciangura, Frederic Bosquet, Chloé Amouyal, Fabrizio Andreelli, M. Halbron, Agnès Hartemann
Publikováno v:
Diabetes technologytherapeutics. 21(7)
Some patients with type 1 diabetes (T1D) are severely noncompliant; they rarely perform self-blood glucose measures and miss insulin injections. Their HbA1c is far above the target rate. Current guidelines do not recommend starting treatment with an
Autor:
P. Richard, Flavie Ader, X Waintraub, P C Charron, M T Thuillot, Eric Villard, Carole Maupain, Estelle Gandjbakhch, Stephanie Rouanet, R I Isnard, Céline Bordet, F. Hidden-Lucet
Publikováno v:
European Heart Journal. 39
Autor:
Nicolas Mansencal, Erwan Donal, Didier Klug, Estelle Gandjbakhch, Dagmar I. Keller, Alexis Hermida, Pierre Cosnay, Jean-Claude Deharo, Vincent Probst, Véronique Fressart, Philippe Chevalier, Etienne Delacrétaz, Fabrice Extramiana, Patrice Scanu, Françoise Hidden-Lucet, Philippe Charron, Stephanie Rouanet
Publikováno v:
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2019, ⟨10.1002/ejhf.1423⟩
European Journal of Heart Failure, 2019, ⟨10.1002/ejhf.1423⟩
European Journal of Heart Failure, Oxford University Press (OUP), 2019, ⟨10.1002/ejhf.1423⟩
European Journal of Heart Failure, 2019, ⟨10.1002/ejhf.1423⟩
International audience; BACKGROUND:Previous studies suggested that genetic status affects the clinical course of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) patients. The aim of this study was to compare the outcome of desmogle
Autor:
Richard Isnard, Marine Thuillot, Françoise Hidden-Lucet, Stephanie Rouanet, Pascale Richard, Carole Maupain, Estelle Gandjbakhch, Flavie Ader, Philippe Charron, Xavier Waintraub
Publikováno v:
European Journal of Heart Failure. 21:253-254
Publikováno v:
Clinical and experimental rheumatology
Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 2015, 33 (5), pp.664-70
Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 2015, 33 (5), pp.664-70
International audience; OBJECTIVES:Fatigue is an important aspect of rheumatoid arthritis (RA). The objective was to assess fatigue levels and its determinants over the first 4 months of tocilizumab (TCZ) treatment in RA patients.METHODS:We performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::388ed527a3b1f7f0113809b111de8f76
https://hal.umontpellier.fr/hal-01950280
https://hal.umontpellier.fr/hal-01950280
Autor:
Antoine Thierry, Yannick Le Meur, Michel Delahousse, Yvon Lebranchu, Nacera Ouali, Denis Glotz, Stephanie Rouanet, Laeticia Albano, Michèle Kessler, Nailya Tagieva, Philippe Lang, François Glowacki, François Vrtovsnik, Maïté Jauréguy, Nassim Kamar, Valérie Garrigue, Jean-Philippe Rerolle, Lionel Couzi, Anne-Elisabeth Heng, Christiane Mousson
Publikováno v:
Transplantation
Transplantation, Lippincott, Williams & Wilkins, 2011, 92 (11), pp.1244-51. ⟨10.1097/TP.0b013e318234e134⟩
Transplantation, Lippincott, Williams & Wilkins, 2011, 92 (11), pp.1244-51
Transplantation, 2011, 92 (11), pp.1244-51. ⟨10.1097/TP.0b013e318234e134⟩
Transplantation, Lippincott, Williams & Wilkins, 2011, 92 (11), pp.1244-51. ⟨10.1097/TP.0b013e318234e134⟩
Transplantation, Lippincott, Williams & Wilkins, 2011, 92 (11), pp.1244-51
Transplantation, 2011, 92 (11), pp.1244-51. ⟨10.1097/TP.0b013e318234e134⟩
International audience; Early posttransplant steroid withdrawal may increase the risk of acute rejection and the occurrence of subclinical acute rejection (SCAR). We assessed the feasibility and safety of early steroid withdrawal in low-risk patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54e70793f5bfe38024acedb607786a3f
https://hal.archives-ouvertes.fr/hal-01151208
https://hal.archives-ouvertes.fr/hal-01151208
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.